FIPROLINE
Brand-level analytics aggregated across all owners and jurisdictions using this name.
Total filings
4
Live
0
Live %
0.0%
Distinct owners
1
Jurisdictions
4
Top NICE
5Pharmaceuticals
Owners Using This Brand Name
| # | Owner | Country | Filings |
|---|---|---|---|
| 1 | VIRBAC | FR | 2 |
| 2 | VIRBAC S.A. | FR | 1 |
| 3 | Virbac SA | FR | 1 |
Geographic Coverage
Filing presence across major commercial IP offices. Color intensity is a log scale of filing count -- darker = more filings. Gaps may indicate expansion opportunities or unprotected markets.
Madrid Protocol (WIPO) · 1
Less
More·Log scale
2 covered · 36 gaps · 38 target jurisdictions
Targets are major commercial IP offices. Gaps may indicate expansion opportunities or unprotected risk.
US○
United States
—
JP○
Japan
—
GB○
United Kingdom
—
IT○
Italy
—
TW○
Taiwan
—
EM○
European Union (EUIPO)
—
CN○
China
—
KR○
South Korea
—
HK○
Hong Kong
—
IN○
India
—
CA○
Canada
—
AU○
Australia
—
NZ○
New Zealand
—
DE○
Germany
—
FR○
France
—
ES○
Spain
—
CH○
Switzerland
—
NL○
Netherlands
—
BX○
Benelux
—
SE○
Sweden
—
NO●
Norway
1· 0 live
PL○
Poland
—
TR○
Turkey
—
RU○
Russia
—
BR○
Brazil
—
MX○
Mexico
—
AR○
Argentina
—
AE○
United Arab Emirates
—
SA○
Saudi Arabia
—
IL○
Israel
—
ZA○
South Africa
—
SG○
Singapore
—
MY○
Malaysia
—
TH○
Thailand
—
ID○
Indonesia
—
PH○
Philippines
—
VN○
Vietnam
—
WO●
Madrid (WIPO)
1· 0 live
By Jurisdiction
| Jurisdiction | Total | Live |
|---|---|---|
| HU | 1 | 0 |
| NO | 1 | 0 |
| RO | 1 | 0 |
| WIPO | 1 | 0 |
Recent Filings
| Date | Owner | Status | NICE | App # |
|---|---|---|---|---|
| 2014-03-24 | Cancelled | 5 | M1400862 | |
| 2014-02-18 | Cancelled | 5 | M 2014 01048 | |
| 2010-07-22 | Cancelled | 5 | 201007703 | |
| 2010-01-27 | Cancelled | 5 | 1032318 |